Abstract B012: KinLET: A phase I dose-finding, safety and pharmacokinetic trial of [177Lu]Lu-edotreotide for the treatment of somatostatin receptor positive tumors in the pediatric population aged 2 to less than 18 years old
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Theodore Laetsch, Raya Saab, Helen Nadel, Nino Shavdia, Serhii Melnyk, Shahanaz Rahman, Cristina Mata Fernández
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4414502474
Cites:
Cited by:
Related to: